Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-18 Purchase |
2021-08-19 5:23 pm |
IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President |
20,000 | $13.99 | $279,790 | 20,000 (Direct) |
View |
| 2020-06-15 Purchase(A) |
2020-06-15 6:39 pm |
ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director |
100,000 | $1.289 | $128,900 | 178,750 (Direct) |
View |
| 2020-06-15 Purchase |
2020-06-15 6:01 pm |
ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director |
100,000 | $1.289 | $128,900 | 178,750 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-24 Option Award |
2024-06-24 7:12 pm |
N/A 2034-06-23 |
TALPHERA INC. | TLPH | ADAMS ADRIAN Director |
15,218 | $0 | 26,386 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:18 pm |
2025-06-06 2034-06-06 |
Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director |
75,000 | $0 | 209,800 (Direct) |
View |
| 2023-10-10 Option Award |
2023-12-13 4:19 pm |
2024-10-10 2033-10-10 |
ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director |
4,068 | $0 | 14,655 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:07 pm |
2024-06-06 2033-06-06 |
Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director |
75,000 | $0 | 179,800 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 6:19 pm |
N/A 2033-02-13 |
IMPEL PHARMACEUTICALS INC | IMPL | ADAMS ADRIAN COB, CEO and President |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-15 7:31 pm |
2022-07-15 2032-07-14 |
ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director |
46,500 | $0 | 242,750 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 4:56 pm |
2023-06-08 2032-06-08 |
Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director |
33,800 | $0 | 124,900 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 5:01 pm |
N/A 2032-01-25 |
IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President |
175,000 | $0 | 175,000 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-26 5:58 pm |
N/A 2031-07-19 |
IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 5:32 pm |
2022-06-17 2031-06-16 |
ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director |
30,000 | $0 | 216,250 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-03 5:27 pm |
2022-06-02 2031-06-02 |
Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director |
33,800 | $0 | 111,200 (Direct) |
View |
Ownership |
2021-04-22 7:01 pm |
N/A 2030-01-22 |
IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President |
0 | $0 | 795,546 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-16 7:13 pm |
2021-06-16 2030-06-15 |
ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director |
22,500 | $0 | 201,250 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:16 pm |
2021-06-05 2030-06-05 |
Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director |
33,800 | $0 | 97,500 (Direct) |
View |